Tetra Technologies Earnings Calls
| Release date | Apr 29, 2026 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0600 |
| EPS Surprise | 100.00% |
| Revenue estimate | 151.2M |
| Revenue actual | 156.253M |
| Revenue Surprise | 3.34% |
| Release date | Feb 25, 2026 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0200 |
| EPS Surprise | -33.33% |
| Revenue estimate | 141.06M |
| Revenue actual | 146.681M |
| Revenue Surprise | 3.98% |
| Release date | Oct 28, 2025 |
| EPS estimate | $0.0400 |
| EPS actual | $0.0400 |
| Revenue estimate | 144.4M |
| Revenue actual | 153.239M |
| Revenue Surprise | 6.12% |
| Release date | Jul 29, 2025 |
| EPS estimate | $0.0900 |
| EPS actual | $0.0900 |
| Revenue estimate | 172.457M |
| Revenue actual | 173.872M |
| Revenue Surprise | 0.82% |
Last 4 Quarters for Tetra Technologies
Below you can see how TTI performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 29, 2025 |
| Price on release | $3.82 |
| EPS estimate | $0.0900 |
| EPS actual | $0.0900 |
| Date | Price |
|---|---|
| Jul 23, 2025 | $3.69 |
| Jul 24, 2025 | $3.76 |
| Jul 25, 2025 | $3.72 |
| Jul 28, 2025 | $3.76 |
| Jul 29, 2025 | $3.82 |
| Jul 30, 2025 | $3.91 |
| Jul 31, 2025 | $4.10 |
| Aug 01, 2025 | $3.86 |
| Aug 04, 2025 | $3.98 |
| 4 days before | 3.52% |
| 4 days after | 4.19% |
| On release day | 2.36% |
| Change in period | 7.86% |
| Release date | Oct 28, 2025 |
| Price on release | $7.78 |
| EPS estimate | $0.0400 |
| EPS actual | $0.0400 |
| Date | Price |
|---|---|
| Oct 22, 2025 | $7.51 |
| Oct 23, 2025 | $7.99 |
| Oct 24, 2025 | $7.84 |
| Oct 27, 2025 | $7.64 |
| Oct 28, 2025 | $7.78 |
| Oct 29, 2025 | $7.21 |
| Oct 30, 2025 | $7.01 |
| Oct 31, 2025 | $7.06 |
| Nov 03, 2025 | $7.17 |
| 4 days before | 3.60% |
| 4 days after | -7.84% |
| On release day | -7.33% |
| Change in period | -4.53% |
| Release date | Feb 25, 2026 |
| Price on release | $11.14 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0200 |
| EPS surprise | -33.33% |
| Date | Price |
|---|---|
| Feb 19, 2026 | $11.24 |
| Feb 20, 2026 | $11.11 |
| Feb 23, 2026 | $11.01 |
| Feb 24, 2026 | $11.20 |
| Feb 25, 2026 | $11.14 |
| Feb 26, 2026 | $9.06 |
| Feb 27, 2026 | $8.66 |
| Mar 02, 2026 | $8.92 |
| Mar 03, 2026 | $8.48 |
| 4 days before | -0.89% |
| 4 days after | -23.88% |
| On release day | -18.67% |
| Change in period | -24.56% |
| Release date | Apr 29, 2026 |
| Price on release | $9.72 |
| EPS estimate | $0.0300 |
| EPS actual | $0.0600 |
| EPS surprise | 100.00% |
| Date | Price |
|---|---|
| Apr 23, 2026 | $9.53 |
| Apr 24, 2026 | $9.69 |
| Apr 27, 2026 | $9.75 |
| Apr 28, 2026 | $9.75 |
| Apr 29, 2026 | $9.72 |
| Apr 30, 2026 | $9.52 |
| May 01, 2026 | $9.45 |
| May 04, 2026 | $9.31 |
| May 05, 2026 | $9.72 |
| 4 days before | 1.94% |
| 4 days after | 0.0515% |
| On release day | -2.01% |
| Change in period | 1.99% |
Tetra Technologies Earnings Call Transcript Summary of Q1 2026
TETRA reported a strong start to 2026 with Q1 revenue of $156 million and adjusted EBITDA of $26 million (noting that excluding prior-year Neptune project benefit these are 10-year highs). Key segment highlights: Industrial Chemicals and Production Testing achieved 10-year high revenues; Completion Fluids & Products revenue up sequentially driven by industrial chemicals and deepwater projects in the Gulf of America and Brazil; Water & Flowback grew modestly despite a 24% decline in U.S. frac fleet activity, aided by automation and cost reductions. Management is maintaining 2026 guidance (single-digit revenue growth vs. 2025; Completion Fluid margins 25–30%; Water & Flowback mid-teens). Strategic progress: Arkansas bromine plant remains on time and on budget (phased build with first production targeted start of 2028; design capacity up to 75 million pounds/year); OASIS produced-water desalination pilot running >96% uptime and multiple engineering/customer engagements underway; a joint venture (Arkansas Magnesium) with Magrathea Metals advancing magnesium demonstration work with engineering studies; lithium development being evaluated given recent LCE price strength and DLE advances. Financials: cash $36 million, total debt $182 million, net leverage ~1.5x; Q1 cash used in operating activities $12 million; total CapEx $19 million (including $8.4 million for Arkansas bromine); adjusted free cash flow was a use of $32 million (base-business adjusted FCF a use of $23.5 million) driven by higher incentive comp, AR build and seasonal inventory—management expects to generate positive base-business free cash flow in 2026 and to reinvest cash into the bromine project. Management views recent Middle East conflict as unlikely to materially harm results (Middle East historically ~5% of revenue) and may create tailwinds for U.S., Latin America and offshore activity. Overall tone: confident execution, prioritized bromine project, continued investment in electrolytes, desalination and critical minerals as part of the One TETRA 2030 strategy.
Sign In
Buy TTI